Somatostatin and analogues in the treatment of cancer

A review

B. Mark Evers, Dilipkumar Parekh, Courtney Townsend, James C. Thompson

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Somatostatin is a naturally occurring cyclic tetradecapeptide that inhibits release of growth hormone and all gastrointestinal hormones. The beneficial effect of somatostatin in the treatment of certain hypersecretory disorders of hormone excess is well recognized; however its clinical usefulness has been limited in the past by its extremely short plasma half-life. The development of long-acting somatostatin analogues has provided clinically useful agents for treatment of hormone-producing tumors. In addition to well-known inhibiting effects on hormone release and actions, recent studies using experimental tumor models have demonstrated an antiproliferative effect of somatostatin and its analogues on growth of a variety of neoplasms. The exact role of somatostatin analogues in cancer therapy has yet to be established; however studies suggest that these agents could provide a useful and relatively nontoxic adjuvant therapy in the treatment of certain tumors. In this review, the oncologic application of somatostatin and possible mechanism of action are examined and current clinical and experimental studies are summarized.

Original languageEnglish (US)
Pages (from-to)190-198
Number of pages9
JournalAnnals of Surgery
Volume213
Issue number3
StatePublished - Mar 1991

Fingerprint

Somatostatin
Neoplasms
Hormones
Gastrointestinal Hormones
Growth Hormone
Half-Life
Theoretical Models
Therapeutics
Growth

ASJC Scopus subject areas

  • Surgery

Cite this

Evers, B. M., Parekh, D., Townsend, C., & Thompson, J. C. (1991). Somatostatin and analogues in the treatment of cancer: A review. Annals of Surgery, 213(3), 190-198.

Somatostatin and analogues in the treatment of cancer : A review. / Evers, B. Mark; Parekh, Dilipkumar; Townsend, Courtney; Thompson, James C.

In: Annals of Surgery, Vol. 213, No. 3, 03.1991, p. 190-198.

Research output: Contribution to journalArticle

Evers, BM, Parekh, D, Townsend, C & Thompson, JC 1991, 'Somatostatin and analogues in the treatment of cancer: A review', Annals of Surgery, vol. 213, no. 3, pp. 190-198.
Evers, B. Mark ; Parekh, Dilipkumar ; Townsend, Courtney ; Thompson, James C. / Somatostatin and analogues in the treatment of cancer : A review. In: Annals of Surgery. 1991 ; Vol. 213, No. 3. pp. 190-198.
@article{3dff2fcf2dd34c12bbeafcc5c87cbaef,
title = "Somatostatin and analogues in the treatment of cancer: A review",
abstract = "Somatostatin is a naturally occurring cyclic tetradecapeptide that inhibits release of growth hormone and all gastrointestinal hormones. The beneficial effect of somatostatin in the treatment of certain hypersecretory disorders of hormone excess is well recognized; however its clinical usefulness has been limited in the past by its extremely short plasma half-life. The development of long-acting somatostatin analogues has provided clinically useful agents for treatment of hormone-producing tumors. In addition to well-known inhibiting effects on hormone release and actions, recent studies using experimental tumor models have demonstrated an antiproliferative effect of somatostatin and its analogues on growth of a variety of neoplasms. The exact role of somatostatin analogues in cancer therapy has yet to be established; however studies suggest that these agents could provide a useful and relatively nontoxic adjuvant therapy in the treatment of certain tumors. In this review, the oncologic application of somatostatin and possible mechanism of action are examined and current clinical and experimental studies are summarized.",
author = "Evers, {B. Mark} and Dilipkumar Parekh and Courtney Townsend and Thompson, {James C.}",
year = "1991",
month = "3",
language = "English (US)",
volume = "213",
pages = "190--198",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Somatostatin and analogues in the treatment of cancer

T2 - A review

AU - Evers, B. Mark

AU - Parekh, Dilipkumar

AU - Townsend, Courtney

AU - Thompson, James C.

PY - 1991/3

Y1 - 1991/3

N2 - Somatostatin is a naturally occurring cyclic tetradecapeptide that inhibits release of growth hormone and all gastrointestinal hormones. The beneficial effect of somatostatin in the treatment of certain hypersecretory disorders of hormone excess is well recognized; however its clinical usefulness has been limited in the past by its extremely short plasma half-life. The development of long-acting somatostatin analogues has provided clinically useful agents for treatment of hormone-producing tumors. In addition to well-known inhibiting effects on hormone release and actions, recent studies using experimental tumor models have demonstrated an antiproliferative effect of somatostatin and its analogues on growth of a variety of neoplasms. The exact role of somatostatin analogues in cancer therapy has yet to be established; however studies suggest that these agents could provide a useful and relatively nontoxic adjuvant therapy in the treatment of certain tumors. In this review, the oncologic application of somatostatin and possible mechanism of action are examined and current clinical and experimental studies are summarized.

AB - Somatostatin is a naturally occurring cyclic tetradecapeptide that inhibits release of growth hormone and all gastrointestinal hormones. The beneficial effect of somatostatin in the treatment of certain hypersecretory disorders of hormone excess is well recognized; however its clinical usefulness has been limited in the past by its extremely short plasma half-life. The development of long-acting somatostatin analogues has provided clinically useful agents for treatment of hormone-producing tumors. In addition to well-known inhibiting effects on hormone release and actions, recent studies using experimental tumor models have demonstrated an antiproliferative effect of somatostatin and its analogues on growth of a variety of neoplasms. The exact role of somatostatin analogues in cancer therapy has yet to be established; however studies suggest that these agents could provide a useful and relatively nontoxic adjuvant therapy in the treatment of certain tumors. In this review, the oncologic application of somatostatin and possible mechanism of action are examined and current clinical and experimental studies are summarized.

UR - http://www.scopus.com/inward/record.url?scp=0026028156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026028156&partnerID=8YFLogxK

M3 - Article

VL - 213

SP - 190

EP - 198

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -